Historical record - last NADAC effective date: 8/21/2024
Product Information
BETAMETHASONE DP AUG 0.05% CRM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1280 per GM under NDC 68462029052. Its NADAC has been published 562 times since Nov 28, 2013.
FDA first approved this application on Sep 23, 2008.
The Low Outlier badge above means this manufacturer's average price in the Betamethasone Dipropionate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029052
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/21/2024
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA078930FDA Approved
9/23/2008
On Market Since
9/23/2008
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP AUG 0.05% CRM has been published 562 times since Nov 28, 2013, and over the history we have for it it has declined 32.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1280 per GM |
|---|---|
| All-time high | $0.2429 (Sep 16, 2015) |
| All-time low | $0.1062 (Apr 17, 2024) |
| Median price | $0.1479 |
| Average price | $0.1625 |
| Largest weekly change | +27.4% (Aug 19, 2015) |
| Weeks tracked | 562 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+5.4%
5Y
-10.7%
All
-32.9%
Last surveyed Aug 28, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP AUG 0.05% CRM?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP AUG 0.05% CRM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1280 per GM (NDC 68462029052), effective Aug 28, 2024.
How has the price of BETAMETHASONE DP AUG 0.05% CRM changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP AUG 0.05% CRM has declined 32.9%. It has been tracked across 562 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP AUG 0.05% CRM?
Since Nov 28, 2013, the NADAC for BETAMETHASONE DP AUG 0.05% CRM has ranged from a low of $0.1062 (Apr 17, 2024) to a high of $0.2429 (Sep 16, 2015), with a median of $0.1479 per GM.
Are there cheaper alternatives to BETAMETHASONE DP AUG 0.05% CRM?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP AUG 0.05% CRM, is $0.1179 per GM — about 8% below BETAMETHASONE DP AUG 0.05% CRM.
Who manufactures BETAMETHASONE DP AUG 0.05% CRM?
BETAMETHASONE DP AUG 0.05% CRM (NDC 68462029052) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.